Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.
about
Thermally Activated Delayed Fluorescence Organic Dots (TADF Odots) for Time-Resolved and Confocal Fluorescence Imaging in Living Cells and In Vivo.AIEgens for dark through-bond energy transfer: design, synthesis, theoretical study and application in ratiometric Hg2+ sensingVisualization of drug delivery processes using AIEgensAggregation-induced emission: mechanistic study of the clusteroluminescence of tetrathienylethene.Image-guided combination chemotherapy and photodynamic therapy using a mitochondria-targeted molecular probe with aggregation-induced emission characteristicsMitochondrial Dynamics Tracking with Two-Photon Phosphorescent Terpyridyl Iridium(III) ComplexesDiscerning the Chemistry in Individual Organelles with Small-Molecule Fluorescent Probes.ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light SourceA highly selective mitochondria-targeting fluorescent K(+) sensor.Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.Multifunctional AIEgens for Future Theranostics.Cellular and Mitochondrial Dual-Targeted Organic Dots with Aggregation-Induced Emission Characteristics for Image-Guided Photodynamic Therapy.Old is new again: a chemical probe for targeting mitochondria and monitoring mitochondrial membrane potential in cells.Smart Probe for Tracing Cancer Therapy: Selective Cancer Cell Detection, Image-Guided Ablation, and Prediction of Therapeutic Response In Situ.Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer.A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells.Fluorescent chemosensors manipulated by dual/triple interplaying sensing mechanisms.Organelle-specific bioprobes based on fluorogens with aggregation-induced emission (AIE) characteristics.Biological and related applications of pillar[n]arenes.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Tuning the singlet-triplet energy gap: a unique approach to efficient photosensitizers with aggregation-induced emission (AIE) characteristics.Synthesis and Evaluation of Tetraarylethylene-based Mono-, Bis-, and Tris(pyridinium) Derivatives for Image-Guided Mitochondria-Specific Targeting and Cytotoxicity of Metastatic Melanoma Cells.Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics.Bioorthogonal Turn-On Probe Based on Aggregation-Induced Emission Characteristics for Cancer Cell Imaging and Ablation.Development and sensing applications of fluorescent motifs within the mitochondrial environment.Fluorescent Coumarin-Artemisinin Conjugates as Mitochondria-Targeting Theranostic Probes for Enhanced Anticancer Activities.A Photoactivatable AIE Polymer for Light-Controlled Gene Delivery: Concurrent Endo/Lysosomal Escape and DNA Unpacking.Biocompatible Red Fluorescent Organic Nanoparticles with Tunable Size and Aggregation-Induced Emission for Evaluation of Blood-Brain Barrier Damage.Mitochondria-targetable carbon quantum dots for differentiating cancerous cells from normal cells.Far-red fluorescent probes for canonical and non-canonical nucleic acid structures: current progress and future implications.Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity.Oxidative Intramolecular 1,2-Amino-Oxygenation of Alkynes under AuI /AuIII Catalysis: Discovery of a Pyridinium-Oxazole Dyad as an Ionic Fluorophore.Aggregation-Induced Emission Active Probe for Light-Up Detection of Anionic Surfactants and Wash-Free Bacterial Imaging.Liquefaction-induced emission enhancement of tetraphenylethene derivatives.Selectively lighting up two-photon photodynamic activity in mitochondria with AIE-active iridium(iii) complexes.pH-Responsive de-PEGylated nanoparticles based on triphenylphosphine-quercetin self-assemblies for mitochondria-targeted cancer therapy.Targeted combinational therapy inducing mitochondrial dysfunction.'AIE + ESIPT' assisted photorelease: fluorescent organic nanoparticles for dual anticancer drug delivery with real-time monitoring ability.Morphology-Tailoring of a Red AIEgen from Microsized Rods to Nanospheres for Tumor-Targeted Bioimaging.
P2860
Q33577751-4D8477D5-B1D1-40B6-A280-766405C5F1C6Q33583752-54CA2DA8-DB10-4F15-B421-38369A552E7AQ33686487-5F225B18-E9BD-4F16-980B-A45E04AAA925Q33686583-8284CA21-7F3A-4AC3-9835-2D9D708C91B3Q33882184-D6328E93-6BD8-4C39-9DB3-FEEFB5A4981DQ35920185-61691723-4995-42BC-B934-CEC04933A588Q36115905-81EDDAB0-D68E-44DA-820B-341CF3917435Q36201763-E5103CE1-EB7A-4DF4-A645-D756CE0774A8Q36749715-38D99AAF-758B-40E0-9C40-D1DD92620A8EQ38539464-7CF28EC4-3044-443B-8B6A-793FE888594FQ38823225-0F996071-6E65-4942-8601-1BB1BA69B2F7Q38826875-D3B7D672-2D1A-4EBC-85BB-2F22D6882439Q38857842-CFEE9E7A-88CB-40F3-85D5-2FDA321F57BBQ38859857-FFEEB33C-5D42-4CA3-9E11-D75486183C05Q38876534-FCB0C4B9-ACD7-455F-A004-D893D8C9FFFBQ38883923-479E4557-6DD2-4504-B059-AE8BD2FD9319Q38973650-C3A76FF5-A05C-43F5-AFF9-F7566B5B6231Q38990259-7358978A-D3D6-412D-B7A1-B6474BE42F01Q39036046-C6F6D540-BE7B-41EB-8EB0-24E61DDAC8F3Q39187880-7F4FA8FE-C2D3-41FB-962B-5949F073E83AQ39400621-86474D08-1E94-4758-A30D-E6098FEAD3A8Q41084525-66311513-25A3-4767-8816-186AE246353FQ42326557-E6ED8094-BE02-4700-95CF-C29386D8CD3EQ46331885-EA99480B-4CFD-47A3-A4A2-6BCC307E1058Q46563550-B8F028B9-6F92-4099-82D0-E3596B899BCCQ46611633-78ADB83C-C423-4B21-82F0-BE89C0396217Q46656097-89DBEB6C-4FA7-440C-B78D-21F563B4A8C4Q46712165-7E1AF6CB-5104-4268-AB5A-86F880E412A3Q47282201-EF731D51-B3D8-4EC6-81F6-7185FFB8B8EAQ47343158-DAA3DA56-BEBD-4877-8CB4-ADE4A732E1D7Q47770627-9B8A6987-83D7-4C50-A8CD-F3F16BD964A3Q47974291-C14F9638-2A54-49A7-A673-F5BF0275327CQ48130694-04EC884C-6C3B-44CE-945D-5174EC8F2969Q48235066-BF53A237-51CA-4015-8DE7-761164F98646Q48264598-612BD57F-309E-46DE-A287-B43C17FEB5E9Q48300374-97853DF6-4360-49CA-9BF9-25F389D6F582Q48360842-22AC933D-F241-4765-B180-F66E075C2EDDQ48373789-0818F13F-0AC8-451D-BA3A-A54B4199C5A7Q50018226-5A1122BA-7C5D-463B-A0D0-EEC3A0D30AA3Q50252598-916C8D03-7EF7-4D41-A5E2-73B6E7CC2B7E
P2860
Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Mitochondria-targeted cancer t ...... uced-emission characteristics.
@en
Mitochondria-targeted cancer t ...... uced-emission characteristics.
@nl
type
label
Mitochondria-targeted cancer t ...... uced-emission characteristics.
@en
Mitochondria-targeted cancer t ...... uced-emission characteristics.
@nl
prefLabel
Mitochondria-targeted cancer t ...... uced-emission characteristics.
@en
Mitochondria-targeted cancer t ...... uced-emission characteristics.
@nl
P2093
P2860
P356
P1476
Mitochondria-targeted cancer t ...... uced-emission characteristics.
@en
P2093
Guangxue Feng
Qinglian Hu
P2860
P304
14225-14229
P356
10.1002/ANIE.201408897
P407
P50
P577
2014-10-15T00:00:00Z